Manila Times
AUCATZYL is the first CAR T therapy approved by the FDA with no requirement for a REMS program (Risk Evaluation Mitigation Strategy)Approval based on
GUADALAJARA, Mexico, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (the "Company” or "GA
CHICAGO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Tidal Financial Group today announced that the Board of Trustees of Tidal Trust II (the Trust) has approved
New York, New York, Nov. 08, 2024 (GLOBE NEWSWIRE) -- New Providence Acquisition Corp. II (Nasdaq: NPAB) (the "Company”) announced today that its bo
ADELAIDE, Australia and CAMBRIDGE, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage
PITTSBURGH, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Matthews International Corporation (Nasdaq GSM: MATW) today announced plans to release its fourth quarte
STAMFORD, Conn., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Grayscale Investments® ("Grayscale”), an asset management firm with over a decade of expertise i
Notification of share transaction by Director of Millicom (Tigo) sharesLuxembourg, November 8, 2024 - Millicom International Cellular S.A. ("Millicom"
ANN ARBOR, Mich., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on November 7, 2024, the Company granted four new emp
NEWTOWN, Pa., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA) announces that Max Wygod, Chief Executive Officer and Executive Chairman, a
Singapore, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Nova Vision Acquisition Corp. (NASDAQ: NOVV, the "Company”), a special purpose acquisition company, ann
Aptose and Hanmi Pharmaceutical Co-developing Triplet Therapy of Tuspetinib with Azacitidine and Venetoclax for Newly Diagnosed AMLSAN DIEGO and TORON
WOBURN, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the developme
ROCKAWAY, N.J., Nov. 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the "Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and w
Multiplexed-engineered, iPSC-derived CAR T Cell Targets Proteins Expressed on Cancer Cells in Response to Cellular Stress and Malignant Transformation
LONDON, Ontario, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. ("Aduro” or the "Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5),
MENLO PARK, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions
CHICAGO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Tidal Financial Group today announced that the Board of Trustees of Tidal Trust II (the Trust) has approved
New York, Nov. 08, 2024 (GLOBE NEWSWIRE) -- AI Transportation Acquisition Corp ("AITR”) (NASDAQ: AITR), a special purpose acquisition company, today
HOUSTON, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Adams Resources & Energy, Inc. (NYSE AMERICAN: AE) ("Adams” or the "Company”), a company engaged in mar
